Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Pathology

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2008.080125PMID 18988797PMCID PMC2626376
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors.

  2008cited by this paper
• VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.

  2007cited by this paper
• Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

  2007cited by this paper
• Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion

  2007cited by this paper
• Regulated ion transport in mouse liver cyst epithelial cells.

  2007cited by this paper
• Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease

  2006cited by this paper
• CFTR, chloride concentration and cell volume: could mammalian protein histidine phosphorylation play a latent role?

  2006cited by this paper
• Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger.

  2006cited by this paper
• Cholangiocyte anion exchange and biliary bicarbonate excretion.

  2006cited by this paper
• Bicarbonate‐rich choleresis induced by secretin in normal rat is taurocholate‐dependent and involves AE2 anion exchanger

  2006cited by this paper
• Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling.

  2006cited by this paper
• Distribution of sodium transporters and aquaporin‐1 in the human choroid plexus

  2006cited by this paper
• Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

  2006cited by this paper
• Liver disease in autosomal recessive polycystic kidney disease

  2005cited by this paper
• Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR.

  2005cited by this paper
• An incredible decade for the primary cilium: a look at a once-forgotten organelle.

  2005cited by this paper
• Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.

  2004cited by this paper
• Autosomal recessive and dominant polycystic kidney diseases.

  2004cited by this paper
• Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid

  2004cited by this paper
• Polycystic kidney disease: new understanding in the pathogenesis.

  2004cited by this paper
• Shared apical sorting of anion exchanger isoforms AE2a, AE2b1, and AE2b2 in primary hepatocytes.

  2004cited by this paper
• Agonist-induced Coordinated Trafficking of Functionally Related Transport Proteins for Water and Ions in Cholangiocytes*

  2003cited by this paper
• Rat hepatocyte aquaporin‐8 water channels are down‐regulated in extrahepatic cholestasis

  2003cited by this paper
• PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats.

  2002cited by this paper
• Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

  2002cited by this paper
• Channel-mediated water movement across enclosed or perfused mouse intrahepatic bile duct units.

  2002cited by this paper
• The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

  2002cited by this paper
• Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene.

  2002cited by this paper
• Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium.

  2002cited by this paper
• Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis.

  2001cited by this paper
• Modified Culture Conditions Enhance Expression of Differentiated Phenotypic Properties of Normal Rat Cholangiocytes

  2000cited by this paper
• Autosomal recessive polycystic kidney disease

  1998cited by this paper
• Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology.

  1998cited by this paper
• Expression cloning and characterization of a renal electrogenic Na+ /HCO3 − cotransporter

  1997cited by this paper
• Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease.

  1996cited by this paper
• The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.

  1996cited by this paper
• Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium.

  1995cited by this paper
• Isolation of small polarized bile duct units.

  1995cited by this paper
• Epidermal growth factor receptor expression is abnormal in murine polycystic kidney.

  1995cited by this paper
• Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver

  1994cited by this paper
• Regulation of bicarbonate-dependent ductular bile secretion assessed by lumenal micropuncture of isolated rodent intrahepatic bile ducts.

  1993cited by this paper
• Secretin stimulates bile ductular secretory activity through the cAMP system.

  1992cited by this paper
• Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease.

  1992cited by this paper
• Autosomal recessive polycystic kidney disease

  1992cited by this paper
• Functional similarities of hepatic cystic and biliary epithelium: Studies of fluid constituents and in vivo secretion in response to secretin

  1990cited by this paper
• Stilbenes inhibit exchange of chloride between blood, choroid plexus and cerebrospinal fluid.

  1989cited by this paper
• Cyclic AMP in secretin choleresis. Evidence for a regulatory role in man and baboons but not in dogs.

  1976cited by this paper
• The nature of the membrane sites controlling anion permeability of human red blood cells as determined by studies with disulfonic stilbene derivatives

  1972cited by this paper
• Chemical Modification of Membranes

  1971cited by this paper
• A FLUORESCENT LABEL FOR THE OUTER COMPONENTS OF THE PLASMA MEMBRANE.

  1964cited by this paper

• A novel gene therapy for ARPKD based on CFTR.

  2025cites this paper
• Aquaporins in Biliary Function: Pathophysiological Implications and Therapeutic Targeting

  2024cites this paper
• Ameliorating liver disease in an autosomal recessive polycystic kidney disease (ARPKD) mouse model.

  2023cites this paper
• NOTCH signalling – a core regulator of bile duct disease?

  2023cites this paper
• Insights into the Function of Aquaporins in Gastrointestinal Fluid Absorption and Secretion in Health and Disease

  2023cites this paper
• A missense mutation in the proprotein convertase gene furinb causes hepatic cystogenesis during liver development in zebrafish

  2022cites this paper
• Quantitative Proteomic Study Unmasks Fibrinogen Pathway in Polycystic Liver Disease

  2022influential citation
• Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment

  2022cites this paper
• Primary cilia loss promotes reactivation of morphogenesis and cyst-fission through a deregulated TGFβ-ECM-Integrin axis in polycystic liver disease

  2022cites this paper
• Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

  2022cites this paper
• Organoids and regenerative hepatology

  2022cites this paper
• Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment

  2022cites this paper
• Congenital Hepatic Fibrosis, Caroli’s Disease, and Other Fibrocystic Liver Diseases

  2021cites this paper
• Applications of organoids in regenerative medicine: a proof-of-concept for biliary injury

  2021cites this paper
• Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.

  2021cites this paper
• Polycystic Liver Diseases

  2020cites this paper
• STAT signaling in polycystic kidney disease.

  2020cites this paper
• Management of portal hypertension and ascites in polycystic liver disease

  2019cites this paper
• Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium.

  2019cites this paper
• Effects of Long-Term Exercise on Liver Cyst in Polycystic Liver Disease Model Rats.

  2019cites this paper
• Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases

  2019cites this paper
• 64 – Fibrocystic Diseases of the Liver

  2018cites this paper
• Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial

  2018cites this paper
• Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.

  2018cites this paper
• Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy.

  2017cites this paper
• New Advances in Polycystic Liver Diseases

  2017cites this paper
• TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling

  2017cites this paper
• Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment

  2017cites this paper
• Hepatic Transporter Function in Liver Disease: Impact on Hepatobiliary Disposition and Pharmacokinetics

  2017influential citation
• Polycystic liver disease: Clinical characterisation and evidence based treatment development

  2017cites this paper
• TGR 5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases via cAMP / G α s signaling Short title : TGR 5 in hepatic cystogenesis

  2017cites this paper
• Therapeutic Targets in Polycystic Liver Disease.

  2017cites this paper
• Polycystic Liver Disease: The Benefits of Targeting cAMP.

  2016cites this paper
• Role of SOX17 in the regulation of the biliary phenotype and in cholangiocarcinogenesis

  2016cites this paper
• Ursodeoxycholic acid in advanced polycystic liver disease : an international multicenter randomized controlled phase 2 trial CURSOR : Controlled trial of URSOdeoxycholic acid to Reduce liver volume in polycystic liver disease

  2016influential citation
• MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.

  2016cites this paper
• Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.

  2016cites this paper
• Hepatocyte Regeneration and Inhibition of Proliferation: Two Sides of a Coin Protects Liver From Failure Following Tissue Loss Ursodeoxycholic Acid in Advanced Polycystic Liver Disease: An International Multicenter Randomized Controlled Phase 2 Trial

  2016cites this paper
• Hepatocyte Regeneration and Inhibition of Proliferation: Two Sides of a Coin.

  2016cites this paper
• TGR5 in the Cholangiociliopathies

  2015cites this paper
• Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

  2015cites this paper
• Overexpression of Aquaporin 1 on cysts of patients with polycystic liver disease.

  2015cites this paper
• Mouse models of primary biliary cirrhosis.

  2015cites this paper
• Polycystic liver diseases: advanced insights into the molecular mechanisms

  2014cites this paper
• HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.

  2014cites this paper
• Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

  2014cites this paper
• Physiology of cholangiocytes.

  2013cites this paper
• EGR1 is critical for gastrin‐dependent upregulation of anion exchanger 2 in gastric cancer cells

  2013cites this paper
• Therapeutic Approaches for Biliary Dysgenesis of the PCK Rat, an Animal Model of CaroliâÂÂs Disease with Congenital Hepatic Fibrosis

  2013cites this paper
• Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.

  2013cites this paper
• Role of AE2 for pHi regulation in biliary epithelial cells

  2013cites this paper
• Water channel proteins in bile formation and flow in health and disease: when immiscible becomes miscible.

  2012cites this paper
• Structure and Function of the Pancreas in the Polycystic Kidney Rat

  2012cites this paper
• Up‐regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis

  2012cites this paper
• The long‐term outcome of patients with polycystic liver disease treated with lanreotide

  2012cites this paper
• MicroRNAs in biliary diseases.

  2012cites this paper
• Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.

  2012cites this paper
• Requirements for ion and solute transport, and pH regulation during enamel maturation

  2012cites this paper
• Therapeutic Potential of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors in Polycystic Kidney Disease

  2012cites this paper
• Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.

  2012cites this paper
• Chapter 56 – Physiology of Cholangiocytes

  2012cites this paper
• Insignificant effect of secretin in rodent models of polycystic kidney and liver disease

  2012cites this paper
• Physiology of Cholangiocytes

  2012cites this paper
• Enamel Pathology Resulting from Loss of Function in the Cystic Fibrosis Transmembrane Conductance Regulator in a Porcine Animal Model

  2011cites this paper
• Enamel Pathology Resulting from Loss of Function in the Cystic Fibrosis Transmembrane Conductance Regulator in a Porcine Animal Model

  2011cites this paper
• Biliary differentiation and bile duct morphogenesis in development and disease.

  2011cites this paper
• Systematic review: the pathophysiology and management of polycystic liver disease

  2011cites this paper
• Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model

  2011cites this paper
• Cholangiopathy: Genetics, Mechanism, and Pathology

  2011cites this paper
• Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal Rat

  2011influential citation
• The primary cilium in different tissues—lessons from patients and animal models

  2011cites this paper
• Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia.

  2010cites this paper
• Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.

  2010cites this paper
• Isolated polycystic liver disease.

  2010cites this paper
• Animal Model of Autosomal Dominant Polycystic Kidney Disease

  2010cites this paper
• Genetics of Fibrocystic Diseases of the Liver and Molecular Approaches to Therapy

  2010cites this paper
• Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease.

  2010cites this paper
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Hepato-Renal Pathology in Pkd 2 ws 25 / Mice , an Animal Model of Autosomal Dominant Polycystic Kidney Disease

  2010cites this paper
• Cholangiociliopathies: genetics, molecular mechanisms and potential therapies

  2009cites this paper
• MicroRNAs in cholangiociliopathies

  2009cites this paper
• Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

  2009cites this paper
• CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

  2009cites this paper
• The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)

  2009cites this paper
• Critical review of clinical trials of bone marrow stem cells in liver disease.

  2008cites this paper